A catalyst system generated in situ from bis(2-methallyl)-cycloocta-1,5-diene-ruthenium(II) and a phosphine was found to efficiently catalyze the addition of thioamides to terminal alkynes with exclusive formation of the anti-Markovnikov thioenamide products. The stereoselectivity of the addition is usually high and controlled by the choice of the phosphine ligand, whereas the (E)-isomers are predominantly formed in the presence of tri(n-octyl)phosphine, the use of bis(dicyclohexylphosphino)methane preferentially leads to the formation of the (Z)-configured thioenamides.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ol801736h | DOI Listing |
J Org Chem
July 2024
School of Chemistry, The Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, United Kingdom.
The stereoselective synthesis of -diaminopimelic acid (-DAP), the key cross-linking amino acid of the peptidoglycan cell wall layer in Gram-negative bacteria, and its biological precursor, l,l-DAP, is described. The key step involved stereoselective reduction of a common enone-derived amino acid by substrate- or reagent-based control. Overman rearrangement of the resulting allylic alcohols, concurrent alkene hydrogenation and trichloroacetamide reduction, and subsequent ruthenium-catalyzed arene oxidation completed the synthesis of each stereoisomer.
View Article and Find Full Text PDFJACS Au
February 2024
State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China.
The disecosteroid natural product gibbosterol A-which has a 14/5-bicyclic framework, a high oxidation state, and a twisted -9,11-epoxy motif-is the first water-soluble 5,10:8,9-disecosteroid. Herein, we report a bioinspired two-phase synthesis of this natural product in only 15 steps from inexpensive ergosterol. In the first (isomerase) phase, the core bicyclic framework is rapidly installed by the skeletal reorganization of ergosterol endoperoxide via a ruthenium-catalyzed dual C-C bond fragmentation.
View Article and Find Full Text PDFNat Commun
January 2024
National Institute of Biological Sciences, 7 Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Angew Chem Int Ed Engl
February 2024
College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, China.
An atom- and step-economical and redox-neutral cascade reaction enabled by asymmetric bimetallic relay catalysis by merging a ruthenium-catalyzed asymmetric borrowing-hydrogen reaction with copper-catalyzed asymmetric Michael addition has been realized. A variety of highly functionalized 2-amino-5-hydroxyvaleric acid esters or peptides bearing 1,4-non-adjacent stereogenic centers have been prepared in high yields with excellent enantio- and diastereoselectivity. Judicious selection and rational modification of the Ru catalysts with careful tuning of the reaction conditions played a pivotal role in stereoselectivity control as well as attenuating undesired α-epimerization, thus enabling a full complement of all four stereoisomers that were otherwise inaccessible in previous work.
View Article and Find Full Text PDFAngew Chem Int Ed Engl
February 2024
School of Chemistry, Key Laboratory of Bioinorganic and Synthetic Chemistry of Ministry of Education, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, Sun Yat-Sen University, 510006, Guangzhou, P. R. China.
A versatile and readily available chiral amide directing group has been developed for the ruthenium(II)-catalyzed asymmetric C-H activation. Asymmetric C-H activation of the related chiral benzamides with various olefins, aldehydes and propargylic alcohols has been accomplished with high stereoselectivities, affording a series of chiral products including 3,4-dihydroisocoumarins (up to 96 % ee), isocoumarins (up to 92 % ee), phthalides (up to 99 % ee), chiral bicyclo[2.2.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!